HLA-G and neoplasm: We also identified subgroup‐specific differences: TIF‐1γ+ patients showed upregulation of HLA‐G, HLA‐DQA1, and BAGE, the latter being a well‐known tumor antigen (51, 52, 53) present in many cancers (54).